Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around 150 points on Tuesday.
美國股票期貨今晨走低,道瓊斯期貨週二下跌約150點。
Shares of HEICO Corporation (NYSE:HEI) fell sharply in today's pre-market trading following fourth-quarter results.
海科航空公司(紐交所:HEI)的股票在今天的美股盤前交易中大幅下跌,原因是發佈了第四季度業績。
Heico reported quarterly earnings of 99 cents per share which beat the analyst consensus estimate of 98 cents per share. The company reported quarterly sales of $1.01 billion which missed the analyst consensus estimate of $1.03 billion.
海科航空報告的季度每股收益爲99美分,超出分析師共識預期的98美分。該公司報告的季度銷售額爲10.1億,低於分析師共識預期的10.3億。
HEICO shares dipped 5.7% to $245.00 in the pre-market trading session.
在美股盤前交易中,海科航空的股票下跌了5.7%,至245.00美元。
Here are some other stocks moving lower in pre-market trading.
以下是一些在美股盤前交易中也有下跌的其他股票。
- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) shares dipped 35.7% to $4.74 in pre-market trading. The company announced interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis.
- Fitell Corporation (NASDAQ:FTEL) shares declined 25.2% to $28.72 in pre-market trading after jumping 28% on Tuesday.
- Radiopharm Theranostics Limited (NASDAQ:RADX) declined 22.2% to $3.51 in pre-market trading.
- Southern States Bancshares, Inc. (NASDAQ:SSBK) fell 9.6% to $32.00 in pre-market trading.
- Worthington Steel, Inc. (NYSE:WS) shares dipped 8.6% to $36.00 in pre-market trading ahead of quarterly earnings.
- Structure Therapeutics Inc. (NASDAQ:GPCR) shares fell 6.3% to $29.50 in pre-market trading. Structure Therapeutics announced selection of lead oral small molecule amylin receptor agonist ACCG-2671 for the treatment of obesity.
- Tesla, Inc. (NASDAQ:TSLA) fell 2.1% to $469.95 in pre-market trading. Baird analyst Ben Kallo maintained Tesla with an Outperform and raised the price target from $280 to $480.
- Corvus Pharmaceuticals, Inc.(納斯達克:CRVS)的股票在美股盤前交易中下跌了35.7%,至4.74美元。該公司發佈了關於隨機、雙盲、安慰劑對照的1期臨床試驗中評估soquelitinib治療中度至重度特應性皮炎患者的中期數據。
- Fitell Corporation(納斯達克:FTEL)的股票在美股盤前交易中下跌了25.2%,至28.72美元,此前該股在週二上漲了28%。
- Radiopharm Theranostics Limited(納斯達克:RADX)的股票在美股盤前交易中下跌了22.2%,至3.51美元。
- Southern States Bancshares, Inc.(納斯達克代碼:SSBK)的股票在美股盤前交易中下跌了9.6%,跌至$32.00。
- 沃辛頓鋼鐵公司(紐交所:WS)股票在美股盤前交易中下跌了8.6%,跌至36.00美元。
- 結構治療公司(納斯達克:GPCR)股票在美股盤前交易中下跌了6.3%,跌至29.50美元。結構治療公司宣佈選擇口服小分子澱粉酶受體激動劑ACCG-2671作爲治療肥胖的主打藥物。
- 特斯拉公司(納斯達克:TSLA)在美股盤前交易中下跌了2.1%,跌至469.95美元。貝爾德分析師本·凱洛對特斯拉維持「跑贏大盤」評級,並將目標價從280美元上調至480美元。
Now Read This:
現在閱讀這個:
- Top 3 Health Care Stocks That May Explode In Q4
- 在2023年第四季度可能爆炸的三大醫療保健股票
譯文內容由第三人軟體翻譯。